Hermetica Superfood Encyclopedia
The Short Answer
Javanese cinnamon bark (Cinnamomum burmannii) is a cassia-type cinnamon whose essential oil contains 73–76% trans-cinnamaldehyde along with procyanidin type-A polymers, which inhibit IKKβ kinase–mediated NF-κB activation to suppress inflammatory mediators COX-2, iNOS, TNF-α, and IL-6 while enhancing insulin-receptor signaling and GLUT4 translocation. Randomized controlled trials of cassia-type cinnamon supplementation (1–6 g/day for 40–120 days) have reported 18–29% reductions in fasting blood glucose and statistically significant improvements in HbA1c, serum triglycerides, and LDL cholesterol in type 2 diabetes cohorts.
CategoryBark
GroupBark
Evidence LevelModerate
Primary Keywordjavanese cinnamon bark benefits
Synergy Pairings4
Javanese Cinnamon Bark — botanical close-up
Health Benefits
**Regulates blood sugar**
levels by enhancing insulin sensitivity and glucose metabolism.
**Enhances metabolic function**
through thermogenic and lipid-modulating effects.
**Improves cardiovascular health**
by supporting healthy circulation and lipid profiles.
**Supports digestion by**: promoting gut motility and balancing the microbiome
**Reduces inflammation and**
microbial imbalances through its potent bioactive compounds.
**Boosts cognitive clarity**
by enhancing cerebral blood flow and antioxidant protection.
Origin & History
Natural habitat
Javanese Cinnamon Bark (Cinnamomum burmannii) is derived from trees native to Indonesia, particularly the islands of Java and Sumatra, thriving in warm, tropical climates and fertile volcanic soils. This aromatic bark is prized for its unique flavor and potent bioactive compounds, offering significant benefits for metabolic and cardiovascular health.
“Javanese Cinnamon Bark has been a foundational spice in Indonesian herbalism for centuries, central to Javanese Jamu medicine and spiritual cleansing practices. Traditionally used to invigorate digestion, restore vitality, and purify the body, it is now recognized for its role in modern metabolic health and cognitive enhancement.”Traditional Medicine
Scientific Research
Multiple randomized controlled trials evaluating cassia-type cinnamon barks, including Cinnamomum burmannii, have demonstrated that daily supplementation of 1–6 g for 40–120 days produces 18–29% reductions in fasting blood glucose, with statistically significant improvements in HbA1c, serum triglycerides, and LDL cholesterol in type 2 diabetes cohorts. In vitro mechanistic studies confirm that trans-cinnamaldehyde and procyanidin type-A polymers extracted from C. burmannii inhibit IKKβ kinase activity and downstream NF-κB nuclear translocation, suppressing expression of COX-2, iNOS, TNF-α, and IL-6. Systematic reviews and meta-analyses of cinnamon supplementation trials, as summarized by the National Center for Complementary and Integrative Health (NCCIH), note that while results are promising, variability in species identification, dosing protocols, and study duration complicates definitive clinical conclusions. Additional research using standardized C. burmannii extracts with verified trans-cinnamaldehyde and coumarin content is needed to establish species-specific efficacy and safety profiles.
Preparation & Dosage
Traditional preparation
General
Traditionally brewed into warming teas and used in Jamu tonics.
General
Modern uses include adaptogenic teas, metabolic supplements, and anti-inflammatory botanical blends.
Recommended dosage
500–1000 mg standardized extract daily
1–2 grams ground bark daily, or .
Nutritional Profile
- Minerals: Manganese, Calcium, Potassium, Magnesium.
- Phytochemicals & Bioactives: Cinnamaldehyde, Eugenol, Polyphenols, Flavonoids, Proanthocyanidins, Plant sterols, Coumarins.
- Other: Prebiotic fiber.
How It Works
Mechanism of Action
Trans-cinnamaldehyde, comprising 73–76% of C. burmannii essential oil, competitively occupies the ATP-binding pocket of IKKβ kinase (inhibitor of nuclear factor kappa-B kinase subunit beta), preventing phosphorylation and subsequent proteasomal degradation of IκBα and thereby blocking NF-κB nuclear translocation and transcription of pro-inflammatory genes including COX-2, iNOS, TNF-α, and IL-6. Procyanidin type-A polymers present in the aqueous extract activate insulin receptor substrate-1 (IRS-1) phosphorylation and enhance PI3K/Akt signaling, promoting GLUT4 transporter translocation to the cell membrane and improving peripheral glucose uptake independent of insulin secretion. These procyanidins also inhibit intestinal α-glucosidase and pancreatic α-amylase activity, delaying carbohydrate digestion and attenuating postprandial glycemic spikes. Additionally, trans-cinnamaldehyde activates TRPA1 channels and Nrf2-mediated antioxidant response element (ARE) pathways, upregulating phase II detoxification enzymes such as heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1).
Clinical Evidence
Current evidence relies primarily on preclinical and in vitro studies, with no published randomized controlled trials for Cinnamomum burmannii specifically. Laboratory studies show ethanol extracts contain 36.67 mg GAE/g total phenolics with free radical scavenging capacity of 1688.85 μmol TE/g against hydroxyl radicals. Water extracts demonstrate lower but significant activity at 583.12 μmol TE/g. Human clinical trials are needed to establish therapeutic dosing and efficacy parameters.
Safety & Interactions
Javanese cinnamon bark (C. burmannii) contains significantly higher coumarin levels (2,100–4,400 mg/kg) than Ceylon cinnamon (C. verum, ~15 mg/kg), and chronic intake exceeding the European Food Safety Authority's tolerable daily intake of 0.1 mg coumarin per kg body weight may pose hepatotoxic risk, particularly in individuals with pre-existing liver conditions. Coumarin is metabolized primarily via CYP2A6, and C. burmannii extracts may inhibit CYP2C9 and CYP3A4 activity in vitro, raising potential interaction concerns with warfarin, statins, and other CYP-metabolized medications; patients on anticoagulant or antidiabetic therapies should consult a healthcare provider before supplementation. High-dose cassia cinnamon may potentiate the hypoglycemic effects of insulin, sulfonylureas, and metformin, increasing the risk of symptomatic hypoglycemia. Pregnant and breastfeeding women are generally advised to limit consumption to culinary amounts, as safety data for supplemental doses remain insufficient.
Synergy Stack
Hermetica Formulation Heuristic
Bark botanical
Cardio & Circulation | Cognition & Focus
Featured in
Cozy
Warming adaptogenic blend for comfort and calm.
Shop Now →
Also Known As
Cinnamomum burmanniiIndonesian cinnamonKorintje cinnamonBatavia cassiaPadang cassia
Frequently Asked Questions
What is the difference between Javanese cinnamon and Ceylon cinnamon?
Javanese cinnamon (Cinnamomum burmannii) is a cassia-type cinnamon native to Southeast Asia with 73–76% trans-cinnamaldehyde in its essential oil and high coumarin levels (2,100–4,400 mg/kg), while Ceylon cinnamon (Cinnamomum verum) from Sri Lanka has a milder flavor, lower cinnamaldehyde content, and negligible coumarin (~15 mg/kg). Because of its higher coumarin content, Javanese cinnamon should be consumed in moderation, especially as a daily supplement.
Is Javanese cinnamon bark good for diabetes and blood sugar control?
Randomized controlled trials of cassia-type cinnamons, including C. burmannii, have shown that 1–6 g/day for 40–120 days can reduce fasting blood glucose by 18–29% and improve HbA1c, triglycerides, and LDL cholesterol in type 2 diabetes patients. The mechanism involves procyanidin type-A polymers enhancing insulin receptor signaling and GLUT4 translocation, as well as inhibiting α-glucosidase to reduce postprandial glucose spikes. However, the NCCIH notes that more high-quality, species-specific research is needed for definitive clinical recommendations.
How much coumarin is in Javanese cinnamon bark, and is it safe?
Cinnamomum burmannii contains among the highest coumarin levels of all commercial cinnamon species, ranging from 2,100 to 4,400 mg/kg of bark, compared to roughly 15 mg/kg in Ceylon cinnamon. The European Food Safety Authority sets a tolerable daily intake at 0.1 mg coumarin per kg body weight, meaning a 70 kg adult should not exceed about 7 mg of coumarin daily. At typical supplemental doses of 1–6 g, coumarin intake from C. burmannii can approach or exceed this threshold, so regular liver function monitoring may be advisable for chronic users.
What are the main bioactive compounds in Javanese cinnamon bark?
The primary bioactive compound is trans-cinnamaldehyde, which constitutes 73–76% of the essential oil and is responsible for anti-inflammatory NF-κB inhibition and TRPA1/Nrf2 antioxidant pathway activation. Procyanidin type-A polymers in the water-soluble fraction drive insulin-sensitizing effects via IRS-1/PI3K/Akt signaling and GLUT4 translocation. Other constituents include eugenol, cinnamate esters, and coumarin, which contribute to antimicrobial and aromatic properties but also necessitate dose-dependent safety considerations.
Can Javanese cinnamon bark interact with medications?
Yes, C. burmannii extracts have shown in vitro inhibition of CYP2C9 and CYP3A4 enzymes, which may affect metabolism of warfarin, statins, certain antihypertensives, and other CYP-dependent drugs. Its high coumarin content could theoretically potentiate the anticoagulant effects of warfarin and increase bleeding risk. Additionally, its insulin-sensitizing procyanidins may enhance the glucose-lowering effects of metformin, sulfonylureas, and exogenous insulin, increasing hypoglycemia risk; patients on these medications should consult their healthcare provider before adding cassia cinnamon supplements.
What is the best form of Javanese cinnamon bark for maximum absorption and effectiveness?
Javanese cinnamon bark is most bioavailable in standardized extract form, which concentrates the active compounds like cinnamaldehyde and procyanidins compared to whole bark powder. Extracts typically achieve better absorption rates in the digestive system and deliver more consistent dosing per serving. However, whole bark powder retains additional fiber benefits for digestive support, making the choice dependent on your primary health goal.
Is Javanese cinnamon bark safe for pregnant women and nursing mothers?
While Javanese cinnamon bark has lower coumarin content than cassia varieties, pregnant and nursing women should consult their healthcare provider before supplementing, as safety data in these populations is limited. High doses may potentially stimulate uterine contractions or affect lactation, though culinary amounts in food are generally considered safe. Medical supervision is recommended to determine if supplementation is appropriate for individual circumstances.
How does Javanese cinnamon bark compare to other cinnamon varieties for metabolic and cardiovascular benefits?
Javanese cinnamon bark falls between Ceylon cinnamon (milder, lower coumarin) and cassia cinnamon (more potent but higher coumarin risk) in terms of bioactive strength and safety profile. Research suggests Javanese cinnamon delivers substantial improvements in insulin sensitivity and lipid profiles while maintaining a more favorable coumarin-to-benefit ratio than cassia. This makes it a practical middle-ground option for those seeking metabolic support without the coumarin concerns of cassia varieties.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w javanese-cinnamon-bark curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
